文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

急性冠状动脉综合征患者的肾功能不全、冠状动脉病变复杂性及不良心血管结局

Renal Dysfunction, Coronary Artery Lesion Complexity, and Adverse Cardiovascular Outcomes in Patients With Acute Coronary Syndrome.

作者信息

Chen Qiang, Li Yike, Yang Siqi, He Haoming, Xie Yingying, Wang Wei, Wang Long, Gao Yanxiang, Cai Lin, Xiong Shiqiang, Zheng Jingang

机构信息

Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, 100029 Beijing, China.

Department of Cardiology, China-Japan Friendship Hospital, 100029 Beijing, China.

出版信息

Rev Cardiovasc Med. 2025 Jul 23;26(7):38389. doi: 10.31083/RCM38389. eCollection 2025 Jul.


DOI:10.31083/RCM38389
PMID:40776972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12326429/
Abstract

BACKGROUND: Renal dysfunction is linked to both the complexity of coronary artery lesions and the prognosis of acute coronary syndrome (ACS). However, the nature of this intricate relationship remains unclear. Therefore, this study aimed to investigate the mechanisms through which coronary lesion complexity mediates the association between renal dysfunction and adverse cardiovascular outcomes in patients with ACS. METHODS: This analysis included 1400 ACS patients who underwent percutaneous coronary intervention (PCI). Renal function was assessed using the estimated glomerular filtration rate (eGFR), calculated according to the 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, which incorporates both creatinine and cystatin C. Coronary lesion complexity was evaluated using the baseline SYNTAX score (bSS). The associations among eGFR, bSS, and major adverse cardiovascular events (MACEs) were examined using survival analysis, restricted cubic spline (RCS) analysis, and mediation analysis. RESULTS: A total of 229 MACEs (16.4%) occurred over a median follow-up of 31.03 (27.34, 35.06) months, including 99 all-cause deaths (7.0%), 41 myocardial infarctions (2.9%), and 123 unplanned revascularizations (8.9%). After multivariate adjustment, both the eGFR and bSS significantly predicted MACEs across the total population and various subgroups. Mediation analysis showed that bSS mediated 16.49%, 14.76%, 12.87%, and 11.95% of the correlation between eGFR and MACEs in different adjusted models. CONCLUSION: The relationship between renal dysfunction and MACEs in ACS patients is partially mediated by coronary lesion complexity. This finding underscores the importance of integrating kidney function assessments with coronary anatomical evaluations to develop individualized risk stratification strategies.

摘要

背景:肾功能不全与冠状动脉病变的复杂性以及急性冠状动脉综合征(ACS)的预后均相关。然而,这种复杂关系的本质仍不清楚。因此,本研究旨在探讨冠状动脉病变复杂性介导ACS患者肾功能不全与不良心血管结局之间关联的机制。 方法:本分析纳入了1400例接受经皮冠状动脉介入治疗(PCI)的ACS患者。使用根据2021年慢性肾脏病流行病学协作组(CKD-EPI)方程计算的估计肾小球滤过率(eGFR)评估肾功能,该方程纳入了肌酐和胱抑素C。使用基线SYNTAX评分(bSS)评估冠状动脉病变复杂性。采用生存分析、限制性立方样条(RCS)分析和中介分析研究eGFR、bSS与主要不良心血管事件(MACE)之间的关联。 结果:在中位随访31.03(27.34,35.06)个月期间,共发生229例MACE(16.4%),包括99例全因死亡(7.0%)、41例心肌梗死(2.9%)和123例非计划血管重建(8.9%)。多变量调整后,eGFR和bSS在总体人群及各个亚组中均显著预测MACE。中介分析显示,在不同调整模型中,bSS介导了eGFR与MACE之间相关性的16.49%、14.76%、12.87%和11.95%。 结论:ACS患者肾功能不全与MACE之间的关系部分由冠状动脉病变复杂性介导。这一发现强调了将肾功能评估与冠状动脉解剖评估相结合以制定个体化风险分层策略的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/61156f52c450/2153-8174-26-7-38389-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/c910b01d657e/2153-8174-26-7-38389-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/d05e401bbad0/2153-8174-26-7-38389-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/16e921a44ae3/2153-8174-26-7-38389-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/7812fe9c6209/2153-8174-26-7-38389-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/61156f52c450/2153-8174-26-7-38389-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/c910b01d657e/2153-8174-26-7-38389-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/d05e401bbad0/2153-8174-26-7-38389-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/16e921a44ae3/2153-8174-26-7-38389-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/7812fe9c6209/2153-8174-26-7-38389-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/12326429/61156f52c450/2153-8174-26-7-38389-g5.jpg

相似文献

[1]
Renal Dysfunction, Coronary Artery Lesion Complexity, and Adverse Cardiovascular Outcomes in Patients With Acute Coronary Syndrome.

Rev Cardiovasc Med. 2025-7-23

[2]
Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.

Cardiovasc Diabetol. 2024-5-16

[3]
Impact of the 2021 Chronic Kidney Disease Epidemiology Collaboration glomerular filtration rate estimating equation on risk of healthcare utilization for hospitalizations for cardiovascular and kidney disease.

Nephron. 2025-8-4

[4]
Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome.

BMC Cardiovasc Disord. 2025-7-7

[5]
Evaluation of the Atherogenic Index of Plasma in the Prognostic Value of Ischemic Heart Failure Post-Percutaneous Coronary Intervention.

Rev Cardiovasc Med. 2025-6-30

[6]
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.

J Am Coll Cardiol. 2025-5-13

[7]
Effects of gender affirming hormone therapy with testosterone on renal function of assigned female at birth transgender people: a meta-analysis.

Front Endocrinol (Lausanne). 2025-6-12

[8]
Adoption of CKD-EPI (2021) for Glomerular Filtration Rate Estimation: Implications for UK Practice.

Nephron. 2025

[9]
Does diabetes status modify the association between the triglyceride-glucose index and major adverse cardiovascular events in patients with coronary heart disease? A systematic review and meta-analysis of longitudinal cohort studies.

Cardiovasc Diabetol. 2025-8-4

[10]
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].

Epidemiol Prev. 2013

本文引用的文献

[1]
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.

N Engl J Med. 2024-7-11

[2]
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

Kidney Int. 2024-4

[3]
Increased Subclinical Coronary Artery Pathology in Type 2 Diabetes With Albuminuria.

Diabetes. 2024-3-1

[4]
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.

Circulation. 2024-2-6

[5]
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.

Circulation. 2023-11-14

[6]
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.

Circulation. 2023-11-14

[7]
Towards personalized cardiovascular care: Global Registry of Acute Coronary Events 3.0 score heralds artificial intelligence era.

Eur Heart J. 2023-11-21

[8]
Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes.

JAMA Cardiol. 2023-10-1

[9]
2023 ESC Guidelines for the management of acute coronary syndromes.

Eur Heart J. 2023-10-12

[10]
The cardio-renal-metabolic connection: a review of the evidence.

Cardiovasc Diabetol. 2023-7-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索